Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

5.93
Delayed Data
As of 3:59pm ET
 +0.12 / +2.07%
Today’s Change
4.38
Today|||52-Week Range
7.16
+3.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues16.8M23.0M11.0M1.4M
 
 
 
 
 
Cost of Goods Sold3.9M6.0M3.2M2.3M
 
 
 
 
 
Depreciation And Amortization1.7M1.3M1.4M1.4M
 
 
 
 
 
 
Operating ExpensesGross Income11.2M15.7M6.3M-2.4M
 
 
 
 
 
General Expenses12.7M14.0M8.5M11.4M
 
 
 
 
 
Research And Development2.2M2.9M2.1M2.8M
 
 
 
 
 
Total Operating Expenses18.4M21.3M13.1M15.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.6M1.7M-2.2M-13.7M
 
 
 
 
 
Interest Expense On Debt493.0K418.0K383.0K401.0K
 
 
 
 
 
Other Expenses100.0K991.0K646.0K-47.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.7M2.5M-1.6M-14.0M
 
 
 
 
 
Income Taxes-267.0K-1.3M-52.0K-1.4M
 
 
 
 
 
Minority Interest-382.0K-651.0K-560.0K-3.0M
 
 
 
 
 
Discontinued Operations0.00-109.0K2.3M0.00
 
 
 
Net Income-1.6M504.0K1.3M-9.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.4M56.9M56.9M56.9M
 
 
 
 
 
Shares To Calculate EPS Diluted56.4M57.0M57.0M56.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03$0.01$0.02-$0.17
 
 
 
 
 
EPS Diluted-$0.03$0.01$0.02-$0.17